drugset / Trial / NCT00004733

Timing of Levodopa Treatment in Parkinson's Disease

NCT00004733

RandomizedDouble-blindTreatment

Summary

The ELLDOPA study is a controlled clinical trial in patients with newly diagnosed PD to determine the optimal timing and dosing with levodopa (Sinemet or its generic equivalents).

Timeline

Start
1998-01
Primary completion
Completion
2004-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Levodopa Small molecule

Indications